Genome-wide gene expression profiling to predict resistance to anthracyclines in breast cancer patients

Validated biomarkers predictive of response/resistance to anthracyclines in breast cancer are currently lacking. The neoadjuvant Trial of Principle (TOP) study, in which patients with estrogen receptor (ER)–negative tumors were treated with anthracycline (epirubicin) monotherapy, was specifically de...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Genom Data
Main Authors: Haibe-Kains, B., Desmedt, C., Di Leo, A., Azambuja, E., Larsimont, D., Selleslags, J., Delaloge, S., Duhem, C., Kains, J.P., Carly, B., Maerevoet, M., Vindevoghel, A., Rouas, G., Lallemand, F., Durbecq, V., Cardoso, F., Salgado, R., Rovere, R., Bontempi, G., Michiels, S., Buyse, M., Nogaret, J.M., Qi, Y., Symmans, F., Pusztai, L., D'Hondt, V., Piccart-Gebhart, M., Sotiriou, C.
Format: Artigo
Sprog:Inglês
Udgivet: Elsevier 2013
Fag:
Data in Brief
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4608867/
https://ncbi.nlm.nih.gov/pubmed/26484051
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gdata.2013.09.001
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker